blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2085483

EP2085483 - TEST KIT FOR DETECTING CANCERS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  04.02.2011
Database last updated on 20.05.2024
Most recent event   Tooltip04.02.2011Withdrawal of applicationpublished on 09.03.2011  [2011/10]
Applicant(s)For all designated states
Beijing ACCB Biotech Ltd.
Room 207, Suite C, Beiqing Road No. 103 Yongfeng Industrial Base Haidian District
Beijing 100094 / CN
[2009/38]
Former [2009/32]For all designated states
Beijing Accb Biotech Ltd.
Room 302, Suite B, R&D Plaza Tsinghua Science Park
Beijing 100084 / CN
Inventor(s)01 / XU, Junpu
Rm. 207, Suite C Beiging Road No.103 Yongfeng Industrial Base Haidian District
Beijing 100094 / CN
02 / CHEN, Zhao
Rm. 207, Suite C Beiging Road No.103 Yongfeng Industrial Base Haidian District
Beijing 100094 / CN
03 / ZHOU, Haimeng
Rm. 207, Suite C Beiging Road No.103 Yongfeng Industrial Base Haidian District
Beijing 100094 / CN
04 / DAI, Jie
Rm. 207, Suite C Beiging Road No.103 Yongfeng Industrial Base Haidian District
Beijing 100094 / CN
05 / HE, Biao
Rm. 207, Suite C Beiging Road No.103 Yongfeng Industrial Base Haidian District
Beijing 100094 / CN
 [2009/32]
Representative(s)Dossmann, Gérard, et al
Casalonga & Partners
Bayerstrasse 71-73
80335 München / DE
[N/P]
Former [2009/38]Dossmann, Gérard, et al
Bureau D.A. Casalonga & Josse Bayerstrasse 71/73
80335 München / DE
Former [2009/32]Dossmann, Gérard
Bureau D.A. Casalonga & Josse Bayerstrasse 71/73
80335 München / DE
Former [2009/30]Dossmann, Gérard
Bureau Casalonga & Josse Bayerstrasse 71/73
80335 München / DE
Application number, filing date08700636.711.01.2008
[2009/32]
WO2008CN00081
Priority number, dateCN2006113842914.11.2006         Original published format: CN200610138429
[2009/32]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008067777
Date:12.06.2008
Language:ZH
[2008/24]
Type: A1 Application with search report 
No.:EP2085483
Date:05.08.2009
Language:EN
[2009/32]
Search report(s)International search report - published on:CN12.06.2008
(Supplementary) European search report - dispatched on:EP22.02.2010
ClassificationIPC:C12Q1/44, G01N33/573
[2009/32]
CPC:
C12Q1/42 (EP); G01N33/57484 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/32]
TitleGerman:TESTKIT ZUR ERKENNUNG VON KREBS[2009/32]
English:TEST KIT FOR DETECTING CANCERS[2009/32]
French:NÉCESSAIRE D'ESSAI POUR LA DÉTECTION DE CANCERS[2009/32]
Entry into regional phase14.05.2009Translation filed 
14.05.2009National basic fee paid 
14.05.2009Search fee paid 
14.05.2009Designation fee(s) paid 
14.05.2009Examination fee paid 
Examination procedure14.05.2009Amendment by applicant (claims and/or description)
14.05.2009Examination requested  [2009/32]
31.05.2010Despatch of a communication from the examining division (Time limit: M04)
30.09.2010Reply to a communication from the examining division
28.01.2011Application withdrawn by applicant  [2011/10]
Fees paidRenewal fee
27.01.2010Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]EP0122028  (E Y LAB INC [US]) [X] 1 * see abstract; page 5; claim - * [Y] 2-16;
 [XY]  - KWEI G Y ET AL, "Enzyme activities associated with carcinogen metabolism in liver and nonhepatic tissues of rats maintained on high fat and food-restricted diets.", THE JOURNAL OF NUTRITION JAN 1991, (199101), vol. 121, no. 1, ISSN 0022-3166, pages 131 - 137, XP002565751 [X] 1 * page 132 - page 134; figure 1B * [Y] 2-16
 [Y]  - ONER-IYIDOGAN ET AL, "Evaluation of leukocyte arylsulphatase a, serum interleukin-6 and urinary heparan sulphate following tamoxifen therapy in breast cancer", PHARMACOLOGICAL RESEARCH, ACADEMIC PRESS, LONDON, GB, (20051001), vol. 52, no. 4, ISSN 1043-6618, pages 340 - 345, XP005031016 [Y] 2-16 * page 341 - page 343 *

DOI:   http://dx.doi.org/10.1016/j.phrs.2005.05.008
 [Y]  - LAIDLER P ET AL, "Arylsulfatase A in serum from patients with cancer of various organs", CLINICA CHIMICA ACTA, ELSEVIER BV, AMSTERDAM, NL, vol. 204, no. 1-3, ISSN 0009-8981, (19911231), pages 69 - 77, (19911231), XP024785117 [Y] 2-16 * page 69 - page 73 *

DOI:   http://dx.doi.org/10.1016/0009-8981(91)90218-2
 [Y]  - TÜRKMEN S ET AL, "Evaluation of leukocyte arylsulfatase-A activity in patients with breast cancer and benign breast disease.", CANCER LETTERS 10 MAY 2001, (20010510), vol. 166, no. 1, ISSN 0304-3835, pages 95 - 101, XP002565752 [Y] 2-16 * page 95 - page 97 *

DOI:   http://dx.doi.org/10.1016/S0304-3835(01)00429-3
 [Y]  - KOÇAK HIKMET ET AL, "Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer.", CLINICAL BIOCHEMISTRY AUG 2004, (200408), vol. 37, no. 8, ISSN 0009-9120, pages 673 - 678, XP002565753 [Y] 2-16 * page 673 - page 674 *

DOI:   http://dx.doi.org/10.1016/j.clinbiochem.2004.02.005
 [XY]  - HARINATH B C ET AL, "Arylsulphatases in human brain: assay, some properties, and distribution.", JOURNAL OF NEUROCHEMISTRY FEB 1971, (197102), vol. 18, no. 2, ISSN 0022-3042, pages 237 - 244, XP002565754 [X] 1 * page 237 - page 238 * [Y] 2-16

DOI:   http://dx.doi.org/10.1111/j.1471-4159.1971.tb00562.x
International search[X]JP2004305008  ;
 [X]  - CHRISTOMANOU H. ET AL., "A sensitive fluorescence assay for the simultaneous and separate determination of arylsulphatases A and B", CLINICA CHIMIC ACTA, (1977), vol. 79, no. 3, pages 527 - 531, XP025200640

DOI:   http://dx.doi.org/10.1016/0009-8981(77)90172-3
 [X]  - MERCELIS R. ET AL., "Arylsulphatases A and B in human diploid fibroblasts: differential assay with 4-methylumbelliferylsulphate and AgNO3", CLINICA CHIMIC ACTA, (1979), vol. 93, pages 85 - 92, XP025217850

DOI:   http://dx.doi.org/10.1016/0009-8981(79)90247-X
 [Y]  - WANG M. ET AL., "Observation of arylsulfates activities in urines of patients suffering from blood disease", JOURNAL OF BENGBU MEDICAL COLLEGE, (1993), vol. 18, no. 1, pages 56 - 57, XP008131832
 [Y]  - CHEN T. ET AL., "Clinical application of detecting activities of arylsulphatase B in morning urines", JOURNAL OF CLINICAL LABORATORY SCIENCE, (1996), vol. 14, no. 1, pages 24 - 25
 [A]  - CHEN T. ET AL., "Separation of arylsulphatases in urines by a precipitation method and detection of activities thereof", JOURNAL OF CLINICAL LABORATORY SCIENCE, (1995), vol. 13, no. 4, pages 174 - 175
by applicant   - WOZNIAK, A. ET AL., NEOPLASMA, (2002), vol. 49, no. 1, pages 10 - 5
    - GASA, S. ET AL., CANCER RES, (1980), vol. 40, no. 10, pages 3804 - 9
    - ROZWODOWSKA, M. ET AL., POL MERKURIUSZ LEK, (2004), vol. 17, no. 99, pages 252 - 4
    - CHETRITE, G.S. ET AL., ANTICANCER RES, (2005), vol. 25, no. 4, pages 2827 - 30
    - DZIALOSZYNSKI, L.M. ET AL., CLIN. CHIM. ACTA, (1966), vol. 14, no. 4, pages 450 - 3
    - UCHIMURA, K. ET AL., METHODS IN ENZYMOLOGY, (2006), vol. 416, page 243
    - SHERMAN, W.R. ET AL., BIOCHEM J., (1967), vol. 102, page 905
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.